Pulmonary Valve Disease

Pulmonary valve disease is a general term that includes conditions in which the pulmonary valve—located between the right lower chamber of the heart and the vessel leading to the lungs—does not function normally. This valve may be narrowed, may leak backward, or more rarely may be structurally different because of congenital developmental abnormalities. As a result, blood flow from the heart to the lungs is affected, and over time strain may develop on the right ventricle. ^[1][2][3]

This group of disorders is not a single diagnosis; it includes stenosis, regurgitation (leakage), atretic structure, and postoperative problems. In some people, the problem is congenital; in others, other congenital heart diseases, prior interventions, or more rarely acquired causes play a role. For this reason, the statement “there is a problem with the valve” is not sufficient on its own; the type and severity of the problem are what matter. ^[1][2][4]

What symptoms does it cause?

Symptoms vary according to the type and severity of the valve abnormality. In mild cases, there may be no symptoms for a long time, and the problem may be noticed only when a murmur is heard during examination. In more pronounced cases, shortness of breath, easy fatigue, chest discomfort, palpitations, dizziness, or leg swelling may occur. In infants and children, growth delay, feeding difficulty, or cyanosis may also be part of the picture. ^[1][2][3]

In pulmonary valve regurgitation, blood leaking back into the right side of the heart may lead over time to volume overload. In stenosis, pressure overload becomes the dominant issue because blood has difficulty passing through the valve. In both situations, the right ventricle may be affected in the long term. Complaints such as reduced exercise capacity and newly developed palpitations should be reassessed by the physician providing follow-up care. ^[1][2][4]

What causes it?

A substantial proportion of pulmonary valve diseases are congenital in origin. Pulmonary valve stenosis is one of the common examples encountered in childhood. In some people, pulmonary valve regurgitation may develop years after surgery for congenital conditions such as tetralogy of Fallot. More rarely, infections, connective tissue disorders, or other cardiovascular diseases may also affect the valve. ^[1][2][3]

Understanding the cause directly affects treatment timing. Not every valve problem requires immediate intervention. Some people are monitored only with regular echocardiography, whereas in others intervention or valve replacement becomes necessary. The presence of symptoms, the extent to which the right ventricle is affected, and accompanying cardiac defects are all important in the decision-making process. ^[1][2]

How is it diagnosed?

The first clue is often a murmur heard during physical examination. Echocardiography is then the fundamental assessment tool; it evaluates the opening and closing characteristics of the valve, the degree of stenosis or regurgitation, and the condition of the right-sided heart chambers. When necessary, additional tests such as electrocardiography, cardiac MRI, exercise testing, and catheterization may also be planned. ^[2][3][4]

The follow-up plan is based not only on current symptoms but also on imaging findings. In some people, right ventricular enlargement or increased load may develop before symptoms are felt. For this reason, the assumption “I have no symptoms, so nothing can be wrong” is not always correct. Regular cardiology follow-up is especially important in people with a history of congenital heart disease. ^[1][2][4]

What are the treatment options?

Treatment varies according to the type and severity of the valve disorder. In mild cases, observation alone may be sufficient. In selected patients in whom stenosis is the predominant problem, catheter-based interventions such as balloon valvuloplasty may be considered. In severe regurgitation or complex structural abnormalities, surgical repair or valve replacement may come into discussion. In some patients, transcatheter valve implantation may also be appropriate. ^[1][2][4]

Medication usually does not eliminate the mechanical problem in the valve itself, but it may help manage arrhythmias, edema, or symptoms of heart failure. Therefore, the goal of treatment is not only symptom relief, but also long-term protection of the right side of the heart. Intervention should be neither too early nor too late; the proper timing is determined by follow-up data. ^[1][2][3]

When should a doctor be consulted?

A doctor should be consulted if there is newly developed exertional shortness of breath, palpitations, fainting, chest pain, leg swelling, or a marked decline in performance in someone with known valve disease. In children, cyanosis, feeding difficulty, easy fatigability, or poor growth are particularly important. If symptoms are sudden and severe, emergency evaluation may be required. ^[1][2][3]

Pulmonary valve disease can vary greatly from person to person. This content provides a general framework; individualized treatment and follow-up require cardiology evaluation. With correct classification and regular monitoring, the risk of complications can often be managed more effectively. ^[1][2][4]

What issues are monitored during follow-up?

In pulmonary valve disease, follow-up is not limited to looking only at the severity of the valve abnormality. The size and strength of the right ventricle, the development of arrhythmias, exercise capacity, and other associated congenital heart problems are also monitored. People diagnosed in childhood should not stop follow-up completely even after reaching adulthood, because a problem that initially appeared mild may progress over the years, or long-term consequences of earlier surgeries may emerge. ^[1][2][3]

In some patients, assessment may be needed regarding suitability for sports, pregnancy planning, or cardiac evaluation before other operations. Such decisions are made according to the type and degree of the valve disorder and right heart function. For this reason, follow-up appointments for people with pulmonary valve disease are not merely routine formalities; they are important consultations that may influence future life decisions. ^[1][2][4]

When does it become time to intervene?

The timing of intervention is usually determined by assessing symptoms, echocardiographic measurements, and the effect on the right ventricle together. Meaningful deterioration in the valve may develop even before a person feels very unwell. Conversely, some complaints may worsen for reasons unrelated to the valve. For this reason, the decision-making process is based not only on symptoms but also on objective cardiologic data. Correct timing aims both to prevent unnecessary early intervention and to avoid waiting so long that permanent strain develops on the heart. ^[1][2][4]

FAQ

Is pulmonary valve disease a single disease?
No. It is a broad group that includes stenosis, regurgitation, atretic structure, and other structural abnormalities. ^[1][2]

Can it progress without causing symptoms?
Yes. Some mild to moderate cases may remain asymptomatic for a long time. ^[1][2][4]

What is the most important test for diagnosis?
Echocardiography is the primary test; additional tests such as MRI or catheterization may be used when needed. ^[2][3]

Does every patient need surgery?
No. Some patients are followed with regular monitoring only, whereas others require intervention or surgery. ^[1][2]

Are palpitations important?
Yes. Newly developed palpitations or a fainting sensation may require reevaluation. ^[1][2]